The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis

Breast Cancer Research

Volumn 12, Issue 3, 2010, Pages

  McCready, Jessica ^a,b   Arendt, Lisa M ^a,b   Rudnick, Jenny A ^a,b   Kuperwasser, Charlotte ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

ANGIOGENESIS; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER GROWTH; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; LACTATION; LIFESPAN; MACROPHAGE; MENOPAUSE; METASTASIS; OBESITY; OVERALL SURVIVAL; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; PROGNOSIS; REVIEW; STATISTICAL SIGNIFICANCE; STROMA; SURVIVAL TIME; TISSUE; BREAST; BREAST TUMOR; FEMALE; PATHOLOGY; STROMA CELL;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MENOPAUSE; PREGNANCY; PROGNOSIS; STROMAL CELLS;

EID: 78149481136     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2578     Document Type: Review

References (111)

1. American Cancer S Breast Cancer Facts and Figures 2007-2008 2008, Atlanta: American Cancer Society, Inc, American Cancer S.
2. Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer 2003, 39:2632-2642. 10.1016/S0959-8049(03)00669-5, 14642925.
3. Klauber-DeMore N. Tumor biology of breast cancer in young women. Breast Dis 2005, 23:9-15.
4. Colditz GA. Epidemiology of breast cancer. Findings from the nurses' health study. Cancer 1993, 71(4 Suppl):1480-1489.
5. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004, 96:218-228. 10.1093/jnci/djh025, 14759989.
6. Albrektsen G, Heuch I, Kvale G. The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 1995, 72:480-484. 2033982, 7640236.
7. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009, 14:87-98. 2693784, 19381788, 10.1007/s10911-009-9119-7.
8. Keinan-Boker L, Lerner-Geva L, Kaufman B, Meirow D. Pregnancy-associated breast cancer. Isr Med Assoc J 2008, 10:722-727.
9. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006, 6:281-291. 10.1038/nrc1839, 16557280.
10. Litwiniuk M, Breborowicz E, Breborowicz D, Filas V, Breborowicz J. Steroid hormone status and HER2/neu expression in pregnancy-associate breast cancer. J Clin Oncol 2007, 25:21115.
11. Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008, 112:71-78.
12. Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, Simozuma K, Enomoto K, Fujiwara K, Nanasawa T, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 1992, 83:1143-1149.
13. Bladstrom A, Anderson H, Olsson H. Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study. Clin Breast Cancer 2003, 4:280-285. 10.3816/CBC.2003.n.033, 14651773.
14. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Erien D, Collins J, Snyder R, Thürlimann B, Fey MF, Mendiola C, Werner ID, Simoncini E, Crivellari D, Gelber RD, Goldhirsch A, . International Breast Cancer Study Group Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004, 15:875-884. 10.1093/annonc/mdh222, 15151943, International Breast Cancer Study Group.
15. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638. 10.1056/NEJMoa021423, 12711737.
16. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjønneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quirós JR, Martínez C, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004, 111:762-771. 10.1002/ijc.20315, 15252848.
17. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000, 152:514-527. 10.1093/aje/152.6.514, 10997541.
18. Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, Adami HO, Trichopoulos D, Willett WC. Dual effect of parity on breast cancer risk. Eur J Cancer 1994, 30A:969-973. 10.1016/0959-8049(94)90125-2, 7946593.
19. Janerich DT, Hoff MB. Evidence for a crossover in breast cancer risk factors. Am J Epidemiol 1982, 116:737-742.
20. Moore HC, Foster RS. Breast cancer and pregnancy. Semin Oncol 2000, 27:646-653.
21. Olson SH, Zauber AG, Tang J, Harlap S. Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology 1998, 9:669-671. 10.1097/00001648-199811000-00019, 9799180.
22. Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at any birth and breast cancer risk. Int J Cancer 1983, 31:701-704. 10.1002/ijc.2910310604, 6862681.
23. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994, 331:5-9. 10.1056/NEJM199407073310102, 8202106.
24. Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology 2001, 12:68-73. 10.1097/00001648-200101000-00012, 11138822.
25. Silberstein GB. Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res 2001, 3:218-223. 138685, 11434872, 10.1186/bcr299.
26. Djonov V, Andres AC, Ziemiecki A. Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech 2001, 52:182-189. 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.0.CO;2-M, 11169866.
27. D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA, Chodosh LA. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002, 16:2034-2051. 10.1210/me.2002-0073, 12198241.
28. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996, 76:69-125.
29. Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z, Bissell MJ. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol 1998, 153:457-467. 1852990, 9708806.
30. Ruder AM, Lubin F, Wax Y, Geier A, Alfundary E, Chetrit A. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences. Cancer 1989, 64:196-202. 10.1002/1097-0142(19890701)64:1<196::AID-CNCR2820640134>3.0.CO;2-3, 2731116.
31. Hildreth NG, Kelsey JL, Eisenfeld AJ, LiVolsi VA, Holford TR, Fischer DB. Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst 1983, 70:1027-1031.
32. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 2007, 67:2062-2071. 10.1158/0008-5472.CAN-06-3895, 17332335.
33. Lund E, Adami HO, Bergstrom R, Meirik O. Anthropometric measures and breast cancer in young women. Cancer Causes Control 1990, 1:169-172. 10.1007/BF00053169, 2102287.
34. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007, 14:189-206. 10.1677/ERC-06-0068, 17639037.
35. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development 2000, 127:2269-2282.
36. Ryan GR, Dai XM, Dominguez MG, Tong W, Chuan F, Chisholm O, Russell RG, Pollard JW, Stanley ER. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001, 98:74-84. 10.1182/blood.V98.1.74, 11418465.
37. Patsialou A, Wyckoff J, Wang Y, Goswami S, Stanley ER, Condeelis JS. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res 2009, 69:9498-9506. 10.1158/0008-5472.CAN-09-1868, 19934330.
38. Watson CJ. Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 2006, 8:203. 1557708, 16677411, 10.1186/bcr1401.
39. Radisky DC, Hartmann LC. Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 2009, 14:181-191. 2693781, 19404726, 10.1007/s10911-009-9123-y.
40. Kritikou EA, Sharkey A, Abell K, Came PJ, Anderson E, Clarkson RW, Watson CJ. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 2003, 130:3459-3468. 10.1242/dev.00578, 12810593.
41. Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G. Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 2000, 106:1209-1220. 381435, 11086022, 10.1172/JCI10411.
42. Zhao L, Melenhorst JJ, Hennighausen L. Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3. Mol Endocrinol 2002, 16:2902-2912. 10.1210/me.2001-0330, 12456808.
43. Sohn BH, Moon HB, Kim TY, Kang HS, Bae YS, Lee KK, Kim SJ. Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem J 2001, 360:31-38. 1222199, 11695989, 10.1042/0264-6021:3600031.
44. Nguyen AV, Pollard JW. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 2000, 127:3107-3118.
45. Jager R, Herzer U, Schenkel J, Weiher H. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 1997, 15:1787-1795. 10.1038/sj.onc.1201353, 9362445.
46. Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jäger R, Weiher H, Furth PA. Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 1999, 59:2541-2545.
47. Jerry DJ, Kuperwasser C, Downing SR, Pinkas J, He C, Dickinson E, Marconi S, Naber SP. Delayed involution of the mammary epithelium in BALB/c-p53null mice. Oncogene 1998, 17:2305-2312. 10.1038/sj.onc.1202157, 9811461.
48. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001, 13:534-540. 10.1016/S0955-0674(00)00248-9, 11544020.
49. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999, 9:1441-1447. 10.1016/S0960-9822(00)80113-X, 10607586.
50. Alexander CM, Selvarajan S, Mudgett J, Werb Z. Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 2001, 152:693-703. 2195781, 11266461, 10.1083/jcb.152.4.693.
51. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693. 2119999, 8175886, 10.1083/jcb.125.3.681.
52. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004, 6:R75-91. 400652, 14979920, 10.1186/bcr753.
53. McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, Schedin P. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 2006, 168:608-620. 16436674, 10.2353/ajpath.2006.050677, 1606507.
54. Schedin P, Mitrenga T, McDaniel S, Kaeck M. Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 2004, 41:207-220. 10.1002/mc.20058, 15468292.
55. Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002, 7:177-189. 10.1023/A:1020304003704, 12463738.
56. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001, 70:478-490.
57. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006, 66:11238-11246. 10.1158/0008-5472.CAN-06-1278, 17114237.
58. Quong J, Eppenberger-Castori S, Moore D, Scott GK, Birrer MJ, Kueng W, Eppenberger U, Benz CC. Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res Treat 2002, 76:221-236. 10.1023/A:1020886801674, 12462383.
59. Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 2009, 150:2537-2542. 2689796, 19372199, 10.1210/en.2009-0070.
60. La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, Decarli A. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer 1997, 75:441-444. 2063359, 9020494.
61. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status - a metaanalysis. Int J Cancer 2009, 124:698-712. 10.1002/ijc.23943, 18988226.
62. Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 1996, 68:8-13. 10.1002/(SICI)1097-0215(19960927)68:1<8::AID-IJC2>3.0.CO;2-V, 8895532.
63. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973, 36:207-214. 10.1210/jcem-36-2-207, 4688315.
64. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase expression in health and disease. Recent Prog Horm Res 1997, 52:185-213. discussion 213-184.
65. van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 1985, 45:2900-2906.
66. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006, 13:279-292. 10.1677/erc.1.00729, 16728564.
67. Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 2001, 7:278-291. 10.1046/j.1524-4741.2001.21033.x, 11906437.
68. Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999, 188:237-244. 10.1002/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8, 10419589.
69. Hutson SW, Cowen PN, Bird CC. Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 1985, 38:281-287. 499125, 3973052, 10.1136/jcp.38.3.281.
70. Howard BA, Gusterson BA. Human breast development. J Mammary Gland Biol Neoplasia 2000, 5:119-137. 10.1023/A:1026487120779, 11149569.
71. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002, 11:1048-1053.
72. Brisson J, Morrison AS, Kopans DB, Sadowsky NL, Kalisher L, Twaddle JA, Meyer JE, Henschke CI, Cole P. Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1984, 119:371-381.
73. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976, 37:2486-2492. 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8, 1260729.
74. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 1976, 126:1130-1137.
75. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007, 356:227-236. 10.1056/NEJMoa062790, 17229950.
76. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87:1622-1629. 10.1093/jnci/87.21.1622, 7563205.
77. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001, 10:243-248.
78. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003, 5:R129-135. 314426, 12927043, 10.1186/bcr622.
79. van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH. Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 2007, 25:1323-1328. 10.1200/JCO.2005.04.7332, 17312333.
80. Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2000, 9:911-915.
81. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer 2002, 98:279-283. 10.1002/ijc.10209, 11857420.
82. Reinier KS, Vacek PM, Geller BM. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and postmenopausal women. Breast Cancer Res Treat 2007, 103:343-348. 10.1007/s10549-006-9375-9, 17063272.
83. Verreault R, Brisson J, Deschenes L, Naud F. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 1989, 129:260-268.
84. Daniell HW. Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 1988, 62:429-435. 10.1002/1097-0142(19880715)62:2<429::AID-CNCR2820620230>3.0.CO;2-4, 3383142.
85. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444:860-867. 10.1038/nature05485, 17167474.
86. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461S-465S.
87. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184. 1716210, 17200717, 10.1172/JCI29881.
88. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46:2347-2355. 10.1194/jlr.M500294-JLR200, 16150820.
89. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006, 116:115-124. 1307559, 16341265, 10.1172/JCI24335.
90. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830. 296998, 14679177.
91. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505. 1459069, 16691291, 10.1172/JCI26498.
92. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851. 10.1126/science.1090922, 14764882.
93. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337. 10.1038/nature03096, 15549095.
94. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 2803035, 12490959, 10.1038/nature01322.
95. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004, 101:4966-4971. 387357, 15051869, 10.1073/pnas.0401064101.
96. Shi C, Simon DI. Integrin signals, transcription factors, and monocyte differentiation. Trends Cardiovasc Med 2006, 16:146-152. 10.1016/j.tcm.2006.03.002, 16781947.
97. Berg AH, Lin Y, Lisanti MP, Scherer PE. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am J Physiol Endocrinol Metab 2004, 287:E1178-1188. 10.1152/ajpendo.00002.2004, 15251865.
98. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 2004, 279:28670-28674. 10.1074/jbc.M402558200, 15123726.
99. Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K, Higa M, Zhou YT, Unger RH. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001, 276:5629-5635. 10.1074/jbc.M008553200, 11096093.
100. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 1994, 35:177-193.
101. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002, 51:2929-2935. 10.2337/diabetes.51.10.2929, 12351429.
102. Surmacz E. Obesity hormone leptin: a new target in breast cancer?. Breast Cancer Res 2007, 9:301. 1851379, 17274833.
103. Rose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 2002, 21:1285-1292.
104. Frankenberry KA, Skinner H, Somasundar P, McFadden DW, Vona-Davis LC. Leptin receptor expression and cell signaling in breast cancer. Int J Oncol 2006, 28:985-993.
105. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005, 257:167-175. 10.1111/j.1365-2796.2004.01426.x, 15656875.
106. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007, 92:1510-1516. 10.1210/jc.2006-1975, 17213279.
107. Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, Koba W, Deng Y, Pollard JW, Scherer PE. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res 2009, 15:3265-3276. 10.1158/1078-0432.CCR-08-2649, 19447867.
108. Scherer PE, Bickel PE, Kotler M, Lodish HF. Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. Nat Biotechnol 1998, 16:581-586. 10.1038/nbt0698-581, 9624692.
109. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003, 22:6408-6423. 10.1038/sj.onc.1206737, 14508521.
110. Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, Calvert VS, Petricoin EF, Liotta L, Dadachova E, Pestell RG, Lisanti MP, Bonaldo P, Scherer PE. Adipocyte-derived collagen VI aff ects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005, 115:1163-1176. 1077173, 15841211.
111. Zhang Y, Daquinag A, Traktuev DO, Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W, Kolonin MG. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 2009, 69:5259-5266. 10.1158/0008-5472.CAN-08-3444, 19491274.